Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Heckmann

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Antimicrobial Resistance and Infection Control|August 27, 2020
Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organismsChristoph Härtel, Kirstin Faust, Ingmar Fortmann, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 15, 2017
Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO<sub>2</sub> targets: the PHELBI follow-up studyUlrich H Thome, Orsolya Genzel-Boroviczeny, Bettina Bohnhorst, et al.
Neonatology|January 4, 2018
Influence of PCO2 Control on Clinical and Neurodevelopmental Outcomes of Extremely Low Birth Weight InfantsUlrich H Thome, Jens Dreyhaupt, Orsolya Genzel-Boroviczeny, et al.
The Lancet. Respiratory Medicine|June 20, 2015
Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trialUlrich H Thome, Orsolya Genzel-Boroviczeny, Bettina Bohnhorst, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Antimicrobial Resistance and Infection Control|August 27, 2020
Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organismsChristoph Härtel, Kirstin Faust, Ingmar Fortmann, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 15, 2017
Neurodevelopmental outcomes of extremely low birthweight infants randomised to different PCO<sub>2</sub> targets: the PHELBI follow-up studyUlrich H Thome, Orsolya Genzel-Boroviczeny, Bettina Bohnhorst, et al.
Neonatology|January 4, 2018
Influence of PCO2 Control on Clinical and Neurodevelopmental Outcomes of Extremely Low Birth Weight InfantsUlrich H Thome, Jens Dreyhaupt, Orsolya Genzel-Boroviczeny, et al.
The Lancet. Respiratory Medicine|June 20, 2015
Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trialUlrich H Thome, Orsolya Genzel-Boroviczeny, Bettina Bohnhorst, et al.
Pageof 7